title: [Risk of treatment with antivitamin K agents in patients with polycystic kidney. Increased by combination with a salicylate].
authors.forename: J M
authors.initials: JM
authors.lastname: Guy
authors.forename: L
authors.initials: L
authors.lastname: Bouvet
authors.forename: C
authors.initials: C
authors.lastname: Guérin
authors.forename: C
authors.initials: C
authors.lastname: Broyet
authors.forename: M
authors.initials: M
authors.lastname: Lamaud
authors.forename: H
authors.initials: H
authors.lastname: Verneyre
mesh_terms: D000074:Acenocoumarol / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D007690:Polycystic Kidney Diseases / Q000150:complications*; D012459:Salicylates / Q000009:adverse effects
chemical_list: D012459:Salicylates; D000074:Acenocoumarol
vernacular_title: Risque du traitement par les anti vitamines K chez les sujets atteints de polykystose rénale. Majoré par l'association d'un salicylé.